Search results for "slas europe 2018"

Enhanced specificity Cas9-NLS from Streptococcus pyogenes, expressed in Escherichia coli

Peak Proteins' expertise in protein crystallography will enhance Sygnature Discovery’s fragment screening and analysis activities as well as its structure-based drug design capabilities

Curve’s mammalian cell drug discovery platform to enable optimization of novel small molecule drug candidates against MSD targets

New system enables new insights into molecular interactions in label-free HTS and uHTS in drug discovery

The collaboration aims to enable the resolution of challenging forensic investigations and complex relationship cases

Including a new section for embedded organoid assays, and new data on mitochondrial membrane potential assays and phagocytosis assays